Home » Newsletters » BioWorld Science

BioWorld Science

June 28, 2021

View Archived Issues

Asarina reports phase IIa topline data on sepranolone in menstrual migraine

I-Mab receives Chinese clearance to conduct phase Ib study of felzartamab in SLE

China NMPA clears phase I trial of InnoCare's ICP-033 for solid tumors

Lynk cleared to begin clinical trials in China with LNK-01003 for inflammatory bowel disease

SIRPalpha-deficient macrophages orchestrate a potent antitumor immune response under radiotherapy

TPR-1 shows antibacterial activity in a panel of F. tularensis strains and a lethal infection model

Peking University Third Hospital, Chigenovo Co. describe therapies including CYP4V2 and RdCVF

Albireo synthesizes new IBAT/LBAT inhibitors

New TLR7/8/9 antagonists identified at Roche

New HIF-2alpha inhibitors identified at Arcus Biosciences

BCN Peptides patents peptides and peptide dimers derived from ADAM 12

Chemoattenuated Pf sporozoite-based vaccine shows efficacy, good tolerance and immunogenicity

First data presented for diarylquinoline TBAJ-876 as antimycobacterial compound

SAN-711 shows promising activity in rat model of orofacial pain

AstraZeneca initiates phase II/III study of COVID-19 variant vaccine AZD-2816

First-in-human data from ongoing ALPHA2 study of ALLO-501A

New resveratrol derivatives against H. pylori resistance

Neurotrophic signaling deficiency exacerbates Alzheimer's risk factors

Kymera reports interim phase I SAD data on IRAK-4 degrader KT-474

iLeukPulm study of inhaled Leukine for COVID-19 shows improved oxygenation

DSMB recommends continuation of phase Ib study of microbiome ecosystem therapy MaaT-033 in AML

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...